Exelixis reported $567.32M in Cash and Equivalent for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 94.64M 172.32M
Acceleron Pharma XLRN:US $ 336.46M 0.26M
Agios Pharmaceuticals AGIO:US $ 400.22M 568.9M
Akebia Therapeutics AKBA:US $ 207.2M 39.79M
Amgen AMGN:US $ 11969M 5339M
AstraZeneca AZN:LN 7067M 8500M
Bayer BAYN:GR € 4316M 927M
Biomarin Pharmaceutical BMRN:US $ 617.14M 24.39M
Bluebird Bio BLUE:US $ 402.46M 48.99M
Bristol Myers Squibb BMY:US $ 13540M 2516M
Cytokinetics CYTK:US $ 477.64M 440.48M
Dicerna Pharmaceuticals DRNA:US $ 165.76M 55.45M
Eisai 4523:JP Y 283002M 69920M
Eli Lilly And LLY:US $ 3788.2M 568.2M
Esperion Therapeutics ESPR:US $ 103.67M 115.51M
Exelixis EXEL:US $ 567.33M 74.86M
Genmab GEN:DC DK 8729M 748M
Glaxosmithkline GSK:US $ 3453M 50M
Immunogen IMGN:US $ 245.76M 6.22M
IONIS PHARMACEUT IONS:US $ 1987M 1421.88M
Macrogenics MGNX:US $ 190.53M 1.56M
Mirati Therapeutics MRTX:US $ 176.78M 82.21M
Moderna Inc MRNA:US 5.55B 53M
Nektar Therapeutics NKTR:US $ 54.02M 98.33M
Neurocrine Biosciences NBIX:US $ 311.1M 56.9M
Novartis NOVN:VX SF 7211M 2094M
Puma Biotechnology PBYI:US $ 63.95M 25.9M
Seattle Genetics SGEN:US $ 685.17M 271.74M
Takeda 4502:JP Y 607881M 47039M
Ultragenyx Pharmaceutical RARE:US $ 197.54M 93.34M
Xencor XNCR:US $ 41.2M 74.64M
YTE INCY:US $ 1999.02M 201.44M